Effects of four atypical antipsychotics on autonomic nervous system activity in schizophrenia
-
- Hattori Saki
- Department of Psychiatry, Yokohama City University School of Medicine, Japan
-
- Suda Akira
- Department of Psychiatry, Yokohama City University School of Medicine, Japan
-
- Kishida Ikuko
- Department of Psychiatry, Yokohama City University School of Medicine, Japan Fujisawa Hospital, Japan
-
- Miyauchi Masatoshi
- Department of Psychiatry, Yokohama City University School of Medicine, Japan
-
- Fujibayashi Mami
- Division of Physical and Health Education, Setsunan University, Japan
-
- Tsujita Natsuki
- Graduate School of Human and Environmental Studies, Kyoto University, Japan
-
- Ishii Chie
- Fujisawa Hospital, Japan
-
- Ishii Norio
- Fujisawa Hospital, Japan
-
- Moritani Toshio
- Faculty of General Education, Kyoto Sangyo University, Japan
-
- Hirayasu Yoshio
- Department of Psychiatry, Yokohama City University School of Medicine, Japan
抄録
<p>Antipsychotic drugs are associated with autonomic nervous system (ANS) dysfunction in patients with schizophrenia, but the effects of individual atypical antipsychotic drugs are not clear. This study investigated how four atypical antipsychotic drugs -risperidone, olanzapine, quetiapine, and aripiprazole- differ in their effects on ANS activity. A total of 241 Japanese patients with schizophrenia participated in this study. All of the participants received an atypical antipsychotic as monotherapy: 90 participants received risperidone, 68 olanzapine, 52 aripiprazole, and 31 quetiapine. ANS activity was assessed by means of a power spectral analysis of heart rate variability. The quetiapine group showed significantly diminished sympathetic and parasympathetic activity compared with the risperidone and aripiprazole groups and significantly lower sympathetic activity relative to olanzapine. In addition, multiple regression analysis showed that the type of antipsychotic drug significantly influenced ANS activity. We suggest that, among the antipsychotics examined-risperidone, olanzapine, quetiapine, and aripiprazole-quetiapine has the strongest effect on ANS activity.</p>
収録刊行物
-
- 日本薬理学会年会要旨集
-
日本薬理学会年会要旨集 WCP2018 (0), PO3-1-99-, 2018
公益社団法人 日本薬理学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390285697593698048
-
- NII論文ID
- 130007901367
-
- ISSN
- 24354953
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- Crossref
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可